CAEBV

Clinical trials for CAEBV explained in plain language.

Never miss a new study

Get alerted when new CAEBV trials appear

Sign up with your email to follow new studies for CAEBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to tame Epstein-Barr virus in chronic disease

Disease control Recruiting now

This study tests whether combining two drugs, golidocitinib and selinexor, can control chronic active Epstein-Barr virus disease (CAEBVD). About 28 adults with active symptoms will receive the treatment. The goal is to reduce virus levels and improve disease activity.

Matched conditions: CAEBV

Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

CAEBV

Get alerted when new CAEBV trials appear

New drug combo aims to tame Epstein-Barr virus in chronic disease